The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
| ||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| EXELIXIS INC | COM | 30161Q104 | 105,064,389 | 5,412,900 | SH | SOLE | 5,412,900 | 0 | 0 | ||
| ESPERION THERAPEUTICS INC | COM | 29664W105 | 7,000,727 | 4,402,973 | SH | SOLE | 4,402,973 | 0 | 0 | ||
| WISDOMTREE INDIA EARNINGS FUND | COM | 97717W422 | 6,743,252 | 213,800 | SH | SOLE | 213,800 | 0 | 0 | ||
| ISHARES MSCI INDIA ETF | COM | 46429B598 | 6,738,432 | 171,200 | SH | SOLE | 171,200 | 0 | 0 | ||